Results 41 to 50 of about 22,830 (226)

Association between PD-L1 expression with EGFR, ALK, and ROS1 driver oncogene mutations in non-small cell lung cancer

open access: yesIndian Journal of Pathology and Microbiology
Background: Driver mutations and immunological expressions have gained importance in recent years for targeted therapies and immunotherapies of nonsmall cell lung cancer (NSCLC). Aims: This study examined the association between PD-L1 expression and ALK,
Dülger Onur, Yaylım İlhan, Öz Büge
doaj   +1 more source

ROS1 demethylates the ROS1 promoter and reduces expression.

open access: yes, 2015
(A) Methylation of the 5' region of ROS1 (region 1 in Fig 3) was measured in two ros1 missense mutants by bisulfite PCR. WT strains were segregating Col-0 siblings for ros1-7 and were C24 for ros1-2.
Daniela Pignatta (376799)   +3 more
core   +1 more source

DEMETER plays a role in DNA demethylation and disease response in somatic tissues of Arabidopsis

open access: yesEpigenetics, 2019
DNA demethylases function in conjunction with DNA methyltransferases to modulate genomic DNA methylation levels in plants. The Arabidopsis genome contains four DNA demethylase genes, DEMETER (DME), REPRESSOR OF SILENCING 1 (ROS1) also known as DEMETER ...
Ulrike Schumann   +7 more
doaj   +1 more source

Construction of pcDNA3.1-CD74-ROS1 Recombinant Plasmid and Effect of CD74-ROS1 Expression on Proliferation and Migration of Lung Cancer Cells

open access: yesZhongliu Fangzhi Yanjiu, 2018
Objective To construct the recombinant plasmid carrying CD74-ROS1 fusion gene, and explore its effect on migration ability of A549 cells. Methods CD74 and ROS1 genes were obtained through PCR. The CD74-ROS1 fusion gene was constructed by fusion PCR.
WU Yazhou, LI Jia, ZHANG Lei
doaj   +1 more source

A Prediction Model for ROS1-Rearranged Lung Adenocarcinomas based on Histologic Features. [PDF]

open access: yesPLoS ONE, 2016
AIMS:To identify the clinical and histological characteristics of ROS1-rearranged non-small-cell lung carcinomas (NSCLCs) and build a prediction model to prescreen suitable patients for molecular testing.
Jianya Zhou   +8 more
doaj   +1 more source

Technical Feasibility Study of Autonomous Field Robot‐Based on‐the‐go Assessment of Soil Nutrients Using Ion‐Sensitive Field‐Effect Transistors

open access: yesAdvanced Robotics Research, EarlyView.
Autonomous field robots equipped with ISFET‐based sensors enable rapid, spatially resolved soil nutrient analysis directly in the field. An automated system based on the BoniRob platform is presented for standardized on‐site extraction and measurement of key macronutrients and soil pH.
Vadim Riedel   +3 more
wiley   +1 more source

A Hybrid Magnetic Actuation System for Single‐Input Multistates Stabilization: Application to pH‐Responsive Drug Delivery

open access: yesAdvanced Intelligent Systems, EarlyView.
This study presents an integrated proof‐of‐concept robotic platform for targeted delivery applications. A hybrid magnetic actuation system achieves single‐input (z) multistate stabilization (x, y, ϕ, and θ) for precise capsule transport with submillimeter positioning accuracy.
Sejun Park   +6 more
wiley   +1 more source

ROS1-1

open access: yes, 2017
ROS1 is a receptor tyrosine kinase that has recently been shown to undergo gene rearrangements in~1%–2% of non-small cell lung carcinoma (NSCLC) and in a variety of other tumours including cholangiocarcinoma, gastric carcinoma, colorectal carcinoma and ...
Prodipto Pal, Zanobia Khan
core   +1 more source

Progress of non-small-cell lung cancer with ROS1 rearrangement

open access: yesFrontiers in Molecular Biosciences, 2023
ROS1 rearrangement is found in 0.9%–2.6% of people with non-small-cell lung cancers (NSCLCs). Tyrosine kinase inhibitors (TKIs) target ROS1 and can block tumor growth and provide clinical benefits to patients. This review summarizes the current knowledge
Xin Yang   +4 more
doaj   +1 more source

Mouse model for ROS1-rearranged lung cancer. [PDF]

open access: yes, 2013
Genetic rearrangement of the ROS1 receptor tyrosine kinase was recently identified as a distinct molecular signature for human non-small cell lung cancer (NSCLC).
Yasushi Totoki   +26 more
core   +1 more source

Home - About - Disclaimer - Privacy